Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava, HEG Ghaleh… - … -Research and Practice, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …

Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava… - Pathology, Research …, 2022 - europepmc.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …

[HTML][HTML] Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava… - Pathology, Research …, 2023 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …

Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava… - Pathology …, 2023 - pubmed.ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …

Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.

M Motallebnezhad, M Omraninava… - Pathology, Research …, 2022 - europepmc.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …